Efficacy and Safety of Kukoamine B Mesilate in Sepsis Patients

PHASE2RecruitingINTERVENTIONAL

Enrollment

424

Participants

Timeline

Start Date

May 15, 2021

Primary Completion Date

May 30, 2024

Study Completion Date

June 30, 2024

Conditions

Sepsis

Interventions

DRUG

16mg，KB

16mg,Q8h±3min,Day1-Day7

DRUG

Placebos

16mg,Q8h±3min,Day1-Day7

Trial Locations (1)

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

collaborator

Southwest Hospital, China

OTHER

lead

Tianjin Chasesun Pharmaceutical Co., LTD

INDUSTRY